- Abstract
E-Manuscript Article Summaries
- Current Oncology Editorial Office
Array Comparative Genomic Hybridization and Cytogenetic Analysis in Pediatric Acute Leukemias [...]
October 2011 - 18 articles
Array Comparative Genomic Hybridization and Cytogenetic Analysis in Pediatric Acute Leukemias [...]
Recently, Current Oncology received its first journal impact factor of 1.820, and ranking of 129 out of 184, as published in the 2010 Journal Citation Reports, Science Edition (Thomson Reuters, 2011). [...]
This issue of Current Oncology contains a new editorial feature that we are calling “Countercurrents.” In this invited series of short pieces, we hope to challenge some of the received wisdom in oncology. These editorials will be written by Dr. Steve...
If a woman develops invasive breast cancer in the left breast at age 30, the probability of her developing breast cancer in the right breast by age 40 is about 5% (0.5% per year) 1.[...]
To be forced to continue living a life that one deems intolerable when there are doctors who are willing either to end one’s life or to assist one in ending one’s own life, is an unspeakable violation of an individual’s freedom to live—and to die—as...
Distress is a common concern across the cancer trajectory, beginning at diagnosis and extending to the post-treatment phase of cancer and long term [...]
The article by Craighead et al. in this issue of Current Oncology presents a systematic review of the use of hyperbaric oxygen (HBO2) to treat delayed pelvic radiation complications in patients with gynecologic cancer.[...]
Banned in 1981, saccharin has long been considered carcinogenic because it produced bladder tumours in rats. Saccharin is now unbanned, with more than 100 countries worldwide legitimately allowing saccharin as a food sweetening additive[...]
Background: Late radiation tissue injury is a serious complication of radiotherapy for patients with gynecologic malignancies. Strategies for managing pain and other clinical features have limited efficacy; however, hyperbaric oxygen therapy (HBO2) m...
Globally, hepatocellular carcinoma (hcc) is the third most common cause of death from cancer, after lung and stomach cancer. The incidence of hcc in Canada is increasing and is expected to continue to increase over the next decade. Given the high mor...
of 2